United States · FDA National Drug Code directory
Duloxetine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-264_958fae45-5e7a-4f8b-80b7-5934222747b5
- Product NDC
- 67877-264
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Duloxetine
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120501
- Source listing expiry
- 20261231
Source-listed ingredients
- DULOXETINE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-264-01) · 67877-264-01
- 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-264-10) · 67877-264-10
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-264-30) · 67877-264-30
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-264-90) · 67877-264-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →